INCLISIRAN (LEQVIO) Nursing Considerations

What is the generic name?

INCLISIRAN

What is the Trade Name for INCLISIRAN?

LEQVIO

What are the Indications for INCLISIRAN?

• 1 INDICATIONS AND USAGE LEQVIO ¬Æ is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD), who require additional lowering of low-density lipoprotein cholesterol (LDL-C). Limitations of Use The effect of LEQVIO on cardiovascular morbidity and mortality has not been determined. LEQVIO is a small interfering RNA (siRNA) directed to PCSK9 (proprotein convertase subtilisin kexin type 9) mRNA indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD), who require additional lowering of low-density lipoprotein cholesterol (LDL-C). ( 1 ) Limitations of Use : The effect of LEQVIO on cardiovascular morbidity and mortality has not been determined. ( 1 )

References: https://open.fda.gov/